GPS (Galderma Patient Services) for NEMLUVIO™ (nemolizumab-ilto).

GPS (Galderma Patient Services) for NEMLUVIO™ (nemolizumab-ilto).

A seamless treatment experience starts here

From day 1, GPS (Galderma Patient Services) for NEMLUVIO™ can provide guidance and support to help you manage your treatment experience. The support team can help you understand insurance benefits and financial assistance, provide one-on-one education, and help you stay on track, including refill reminders. They can help ensure a seamless start and continuation of your treatment with NEMLUVIO®.

What to expect as you start your treatment

Consider which of the following support programs will be most useful to you:

Image

Quick Start: Those who qualify are able to start NEMLUVIO sooner as their dermatologist works with insurance providers to secure approval

Image

Bridge Program: Helps you access NEMLUVIO if you have a lapse in treatment due to change or loss of insurance, delayed re-authorization, or have exhausted Quick Start supply during pending payer determination

Image

Co-Pay Support: Helps with insurance when NEMLUVIO is covered by commercial insurance

Image

Patient Assistance Program: Helps if you do not have any insurance, your insurance will not cover NEMLUVIO, or your insurance co-pays will create a financial burden and there are no other programs available to help

Image

Injection Training: Available for those who have been prescribed NEMLUVIO and need education on proper self-administration techniques

Image

Nurse Navigators: Your guides to NEMLUVIO, providing you with the knowledge foundation to embark on a successful treatment experience

It's easy to enroll with GPS for NEMLUVIO

You can get started with GPS for NEMLUVIO by completing your enrollment form online today. The GPS for NEMLUVIO support team will be in touch to connect you with the right programs and access to treatment.

If you prefer to enroll over the phone or have questions about GPS for NEMLUVIO, please call 1‑855‑NEMLUVIO, 8:00 AM - 8:00 PM ET, Monday - Friday

If you prefer to enroll over the phone or have questions about GPS for NEMLUVIO, please call 1‑855‑NEMLUVIO, 8:00 AM - 8:00 PM ET, Monday - Friday

If you prefer to enroll over the phone or have questions about GPS for NEMLUVIO, please call 1‑855‑NEMLUVIO,
8:00 AM - 8:00 PM ET, Monday-Friday.

Important Safety Information

Indications: NEMLUVIO® (nemolizumab-ilto) is a prescription medicine used:

  • to treat adults and children 12 years of age and older with moderate-to-severe eczema (atopic dermatitis or AD) in combination with prescription therapies used on the skin (topical) when the eczema is not well controlled by topical therapies alone. It is not known if NEMLUVIO is safe and effective in children with atopic dermatitis under 12 years of age.
  • to treat adults with prurigo nodularis. It is not known if NEMLUVIO is safe and effective in children with prurigo nodularis under 18 years of age.

Do not take NEMLUVIO if you are allergic to nemolizumab-ilto or to any ingredients in NEMLUVIO. Before taking NEMLUVIO, tell your healthcare provider about all of your medical conditions, including if you:

  • are scheduled to receive any vaccination. You should not receive a live vaccine right before or during treatment with NEMLUVIO.
  • are pregnant or plan to become pregnant. It is not known whether NEMLUVIO will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known whether NEMLUVIO passes into your breast milk and if it can harm your baby.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

NEMLUVIO may cause serious side effects, including: allergic reactions (hypersensitivity). Stop using NEMLUVIO and tell your healthcare provider or get emergency help right away if you get any of the following symptoms:

  • Breathing problems or wheezing
  • Swelling of the face, lips, mouth, tongue, or throat
  • Fainting, dizziness, feeling lightheaded
  • Fast pulse
  • Swollen lymph nodes
  • Joint pain
  • Fever
  • Skin rash (red or rough skin)
  • Nausea or vomiting
  • General ill feeling
  • Cramps in your stomach area

The most common side effects of NEMLUVIO include:

  • Eczema: headache, joint pain, hives (itchy red rash or wheals), and muscle aches
  • Prurigo Nodularis: headache and skin rashes: atopic dermatitis (a type of eczema), eczema, and eczema nummular (scattered circular patches)

These are not all of the possible side effects of NEMLUVIO.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Information.